| 靶点: |
IC50: 520 nM (BCL6). |
| 体内研究: |
CCT369260 (compound 1, 15 mg/kg, po, single dose) significantly inhibits BCL6 in OCI-Ly1 DLBCL xenograft model. |
| 参考文献: |
1. Benjamin R Bellenie, et al. Achieving In Vivo Target Depletion through the Discovery and Optimization of Benzimidazolone BCL6 Degraders. J Med Chem. 2020 Apr 23;63(8):4047-4068. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.965 ml |
9.823 ml |
19.647 ml |
| 5 mM |
0.393 ml |
1.965 ml |
3.929 ml |
| 10 mM |
0.196 ml |
0.982 ml |
1.965 ml |
| 50 mM |
0.039 ml |
0.196 ml |
0.393 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |